• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Updates, 31-01-2026: General Updates

    31-01-2026 | 01:44 pm

    AstraZeneca India secured CDSCO approval to market its drug Imfinzi for an additional indication: resectable gastric or gastroesophageal junction adenocarcinoma. This expands the drug's treatment scope and market opportunity in India, boosting its sales potential.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited